Last reviewed · How we verify
NCT04604119
Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic
trial in Sars-CoV2 in 104 participants. Completed in 1 June 2020.
30 May 2020
Quick facts
| Lead sponsor | Sisli Hamidiye Etfal Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 104 |
| Start date | 1 May 2020 |
| Primary completion | 30 May 2020 |
| Estimated completion | 1 June 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Sars-CoV2 — all drugs for Sars-CoV2 →
- Anxiety — all drugs for Anxiety →
- Burnout — all drugs for Burnout →
Sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Who can join
18 and older, any sex, with Sars-CoV2 or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim is to measure anxiety level and burnout frequency of healthcare workers including attending physicians, residents and nurses working at intensive care unit during COVID-19 pandemic. The study protocol had consisted of three parts. The first part was related to demographic details including age, sex, marital status, working position, past medical history. The second part of the survey was validated Turkish form of Beck anxiety inventory (BAI) It has 21 questions. Every question is a somatic symptom of anxiety. Participants scored them regarding how this symptom bothered them past week. Items have four possible answers: not at all (0 point), mildly (1 point), moderate (2 point), severe (3 point). Total anxiety score can be between 0 and 63. Participants were categorized as no or mild anxiety if the total beck anxiety score was between 0-16, and moderate to severe anxiety if it was more than 16 The last part of the survey was validated Turkish form of Maslach Burnout Inventory (MBI) to evaluate components of BOS
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Anxiety and burnout in anesthetists and intensive care unit nurses during the COVID-19 pandemic: a cross-sectional study.
Acar Sevinc S, Metin S, Balta Basi N, Cinar AS, et al · · 2022 · cited 16× · PMID 34324934 · DOI 10.1016/j.bjane.2021.07.011
Verify or expand the search:
- PubMed search for NCT04604119
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sars-CoV2
Currently open trials in the same condition.
- NCT04466683 — Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia · Phase 2 · active not recruiting
- NCT04433364 — COPE - COVID-19 in Pregnancy and Early Childhood · active not recruiting
- NCT04363853 — Tocilizumab Treatment in Patients With COVID-19 · Phase 2 · active not recruiting
- NCT04424992 — The Natural History of Hospitalized COVID-19 Patients · recruiting
Other Sisli Hamidiye Etfal Training and Research Hospital trials
Trials by the same sponsor.
- NCT07334002 — The Effects of Conventional Therapy on Tinnitus, Disability, and Quality of Life in Patients With Tinnitus · NA · not yet recruiting
- NCT07321041 — Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia · recruiting
- NCT07476690 — Effect of rESWT Session Frequency on Spasticity and Function Assessed by Sonoelastography in Children With Cerebral Pals · NA · recruiting
- NCT07166614 — Dexmedetomidine vs Propofol in High-Risk ERCP Patients · NA · recruiting
- NCT07250243 — Turkish Validation and Reliability of the John Hopkins In-Room Independence Scale · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04604119 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sisli Hamidiye Etfal Training and Research Hospital
- Last refreshed: 28 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04604119.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing